Insomnia vs Schemathesis
Feature checklists rarely decide anything. What decides it is the pricing metric, who has to write the tests, and which limitation you can live with.
Entry price
From $12 per user/month (Pro; ~17% off billed annually)
Free tierFree tier available
Free tierWhat drives the bill
The metric that actually scales your invoice.
Free for small teams; Pro lifts the user cap and adds RBAC, and Enterprise at $45 per user/month adds SSO/SCIM and Kong Konnect integration.
Open source. A commercial hosted service exists for reporting and continuous runs.
Free tier
Essentials is free for up to 3 users, including local and cloud projects, CLI and 1,000 mock requests a month.
The CLI and Python library are open source and free.
Open source
Apache-2.0
MIT
Self-hostable
No-code authoring
Languages
Platforms
Fits teams
Adoption
Widely used
Kong · since 2016
Established
Schemathesis · since 2019
Strengths
- Noticeably faster and lighter than Postman for everyday request work.
- Best-in-class GraphQL and gRPC ergonomics.
- Design-first OpenAPI workflow with linting built in.
- Enormous coverage for almost no authoring effort — the schema is the test suite.
- Reliably finds unhandled server errors and schema violations that manual tests miss.
- Failures come with a minimal reproducing case.
Limitations
- A forced-account change in 2023 damaged trust; check the current model before standardising on it.
- Test scripting is less capable than Postman's.
- Smaller ecosystem of shared collections.
- Only as good as your schema; a vague or inaccurate spec produces noise.
- Tests conformance, not business correctness — it cannot know a discount was miscalculated.
- Generated failures can be tedious to triage at first.
Best for
Developers who mainly want a fast client with excellent GraphQL support.
Any team with an accurate OpenAPI spec who wants deep coverage cheaply.
All of these integrate with: OpenAPI, GraphQL, GitHub Actions.
Pricing last reviewed August 2026 and is indicative only — confirm on each vendor’s own page.